In our 2016 CRO Oversight Benchmark Survey, more than 100 clinical operations leaders from life sciences organizations claimed that CRO oversight is seen as a top priority, but yet are not successful in achieving planned oversight goals. In a recent webinar on this subject, Chaucer Life Sciences, U.S. and European based experts specializing in the delivery and adoption of new ways of working in life sciences, outlined some key points to think about when preparing for the upcoming changes, and how technology can speed the necessary work to support the new addendum. There are 5 critical steps Chaucer takes when establishing a strong vendor oversight practice:
Making Sense of ICH E6 (R2): Preparation and Implementation Best Practices Print
Created by: Brian Lederman
Modified on: Tue, 9 Feb, 2021 at 5:10 PM
Did you find it helpful?Send feedback
Sorry we couldn't be helpful. Help us improve this article with your feedback.